All attending UK organisations
UK companies attending Bio-Europe Spring as part of the official delegation
(Click here to search profiles):
UK Delegation: Albumedix, Barrington James, Bionow, BioPartner UK, Bit Bio Ltd, Crystec, Fusion Antibodies, Galen, Ingenza, MediWales, Mereo BioPharma, Nanovery, NuVision Biotherapies, OBN UK, Oncimmune, PharmaVentures, Physiomics, Rosemont Pharmaceuticals, SBA, Scendea, Sekisui, Silence Therapeutics, SomaServe, The National Institute for Health Research (NIHR), Therakind, Tissue Solutions, UK BioIndustry Association (BIA).
Other UK companies associated with the delegation*:
Mogrify
All attending UK companies:4D pharma, Acclime, Accord Healthcare, Adaptimmune, ADVANZ PHARMA, Albumedix, AlphaSense, Antiverse, APM Health, Wilmington, Apple Tree Life Sciences, Aptamer Group, Arecor Therapeutics, Artemida Pharma, Asieris Pharmaceutical, Aspire Pharma, Astellas, Autolus, Babraham Institute Enterprise, Barrington James, BDD Pharma, Bedfont Scientific, Beacon for Rare Diseases, BenevolentAI, BIA, BioCentury, Biogen, Bionow, BioPartner UK, Bit Bio, Boyds, Brainomix, Cancer Research UK, Catalent Pharma Solutions, Charnwood Molecular, Chiesi, Clarivate, Clinigen Group, Compugen, Consilient Health, Coulter Partners, Covington, Crystec, Cumulus Oncology, CWB Consulting, Daewoong Pharmaceutical Co, Delin Ventures, Destiny Pharma, Dotmatics, Drug Discovery Unit, EBD Group, Eisai Europe, Elanco Animal Health, Eli Lilly, Ellipses Pharma, Evaluate, Evgen Pharma, Evotec, Evox Therapeutics, Exscientia, Exvastat, Fareva, F-star Therapeutics, Fusion Antibodies, Galen, GlobalData, Grand Pacific CRO, HC Pharma, Healx, HungaroTrial CRO, Hypo-Stream, Iceni Glycoscience, Inceptua, Infinity BiologiX UK, Informa Connect, Ingenza, Innovent Biologics (Europe), IN-PART, Intelligencia.ai, Intelligent OMICS, IPSEN, Johnson & Johnson Innovation, Kargenera, Kuano, Kyowa Kirin Co, Labcorp, LabGenius, LifeArc, Livzon Pharmaceutical Group, LSX Leaders, Medicines Discovery Institute, Medicxi, MediWales, MedPharm, Mereo Biopharma Group, Mestag Therapeutics, Microbiotica, Midatech Pharma, Mission Therapeutics, Mitsubishi Tanabe Pharma, Mogrify, Monograph Capital, MSD, MVM Partners, Nanomerics, Nanovery, Nature Research, Norgine, NuVision Biotherapies, OBN UK, Oncimmune, OncoBone Ventures, One Nucleus, Ono Pharma UK, Orbit Discovery, Ossianix, Otsuka, Outrun Therapeutics, Phaim Pharma, Pharma Intelligence, PharmaCircle, PharmaVentures, Phion Therapeutics, PhoreMost, Physiomics, Pneumagen, Poolbeg Pharma, PrecisionLife, Prokarium, ProPharma Group, Quadram Institute Bioscience, RBW Consulting, Redx Pharma, Renata, REPROCELL Europe, Research and Innovation Services - University of Dundee, Results Healthcare, Rosemont Pharmaceuticals, Sage Healthcare, Sanome, SBA, Scendea, Scius communications, Sekisui, Shionogi, Silence Therapeutics Pic, Simcere Pharmaceutical Group, Sitryx Therapeutics, SomaServe, Sonrai Analytics, SRG Outsourcing, Standigm, Storm Therapeutics, Stringray Bio / o2h Ventures, SV Health Investors, Tanner Pharma, Teijin Pharma, The National Institute for Health Research, The Pirbright Institute, Therakind, Tissue Solutions, Torreya, Touchlight, tranScrip, Ubiquigent, UCB, University of Edinburgh, ValiRx, Venture Life, Virdis Group, Vivos Technology, WEP Clinical, WuXi Biologics, Wyoming Interactive, X-Chem. (174)
*Delegation companies registered through BioPartner UK and saved €149 - €179.
*Associated companies requested a discount code.
